These data reflected that Oxysophocarpine decreased FGL1 expression through downregulating IL‐6‐mediated JAK2/STAT3 signal pathway in HCC cells and subsequently sensitize anti‐Lag3 therapeutic effect. Here, JAK2 is linked to hepatocellular carcinoma.